ALLERGAN AUSTRALIA PTY LIMITED

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Safety and Efficacy of AGN201781 in Neuropathic Pain

Phase 2
Terminated
Conditions
Neuralgia
Interventions
Drug: AGN201781
Drug: placebo
First Posted Date
2007-09-21
Last Posted Date
2016-02-24
Lead Sponsor
Allergan
Target Recruit Count
9
Registration Number
NCT00533351

Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia

Phase 4
Completed
Conditions
Spasmodic Torticollis
Interventions
Biological: botulinum toxin type A
First Posted Date
2007-09-12
Last Posted Date
2011-12-16
Lead Sponsor
Allergan
Target Recruit Count
145
Registration Number
NCT00528541

A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery

Phase 3
Completed
Conditions
Cataract Extraction
Pain
Inflammation
Interventions
Drug: ketorolac
First Posted Date
2007-09-03
Last Posted Date
2009-10-01
Lead Sponsor
Allergan
Target Recruit Count
248
Registration Number
NCT00524264

A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery

Phase 3
Completed
Conditions
Cataract Extraction
Interventions
Drug: ketorolac eye drops
First Posted Date
2007-08-27
Last Posted Date
2009-10-01
Lead Sponsor
Allergan
Target Recruit Count
263
Registration Number
NCT00521456

A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

First Posted Date
2007-08-20
Last Posted Date
2019-04-23
Lead Sponsor
Allergan
Target Recruit Count
859
Registration Number
NCT00518089

Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

First Posted Date
2007-08-10
Last Posted Date
2009-12-15
Lead Sponsor
Allergan
Target Recruit Count
316
Registration Number
NCT00514852

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

First Posted Date
2007-08-06
Last Posted Date
2019-04-25
Lead Sponsor
Allergan
Target Recruit Count
243
Registration Number
NCT00511706

A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

First Posted Date
2007-08-01
Last Posted Date
2011-11-30
Lead Sponsor
Allergan
Target Recruit Count
578
Registration Number
NCT00509873

Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma

Completed
Conditions
Glaucoma, Open-Angle
First Posted Date
2007-06-15
Last Posted Date
2011-06-01
Lead Sponsor
Allergan
Target Recruit Count
361
Registration Number
NCT00487214

Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema

First Posted Date
2007-04-24
Last Posted Date
2019-04-24
Lead Sponsor
Allergan
Target Recruit Count
253
Registration Number
NCT00464685
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy